martes, 31 de marzo de 2020

Capitol Hill’s coronavirus response delays drug pricing legislation

Capitol Hill’s coronavirus response delays drug pricing legislation

Daily Recap

STAT Plus: Lawmakers’ coronavirus response means delays for drug pricing legislation

By LEV FACHER


SUSAN WALSH/AP
Lawmakers, lobbyists, and drug pricing advocates saw May as a final opportunity this year to pass drug pricing legislation.

No hay comentarios:

Publicar un comentario